Ercan, O.; Dokuyucu, R.; Yuksel, E.; Ozgur, T.
Thymoquinone Versus Metformin in Letrozole-Induced PCOS: Comparative Insights into Metabolic, Hormonal, and Ovarian Outcomes. J. Clin. Med. 2025, 14, 6561.
https://doi.org/10.3390/jcm14186561
AMA Style
Ercan O, Dokuyucu R, Yuksel E, Ozgur T.
Thymoquinone Versus Metformin in Letrozole-Induced PCOS: Comparative Insights into Metabolic, Hormonal, and Ovarian Outcomes. Journal of Clinical Medicine. 2025; 14(18):6561.
https://doi.org/10.3390/jcm14186561
Chicago/Turabian Style
Ercan, Onder, Recep Dokuyucu, Ergun Yuksel, and Tumay Ozgur.
2025. "Thymoquinone Versus Metformin in Letrozole-Induced PCOS: Comparative Insights into Metabolic, Hormonal, and Ovarian Outcomes" Journal of Clinical Medicine 14, no. 18: 6561.
https://doi.org/10.3390/jcm14186561
APA Style
Ercan, O., Dokuyucu, R., Yuksel, E., & Ozgur, T.
(2025). Thymoquinone Versus Metformin in Letrozole-Induced PCOS: Comparative Insights into Metabolic, Hormonal, and Ovarian Outcomes. Journal of Clinical Medicine, 14(18), 6561.
https://doi.org/10.3390/jcm14186561